Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 4 Brain Neoplasms 4 Pancreatic Neoplasms 3 Glioblastoma 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Lung Neoplasms 2 Glioma 2 Esophageal Neoplasms 2 Craniopharyngioma 2 Wilms Tumor 1 Sarcoma 1 Rhabdomyosarcoma 1 Retinoblastoma 1 Resectable Lung Non-Small Cell Carcinoma 1 Recurrent Head and Neck Carcinoma 1 Radiation Injuries 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Meningioma 1 Gliosarcoma 1 Eye Neoplasms 1 Ependymoma 1 Desmoplastic Small Round Cell Tumor 1 Chordoma 1 Chondrosarcoma 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Nivolumab 3 palbociclib 2 Ipilimumab 2 Imatinib Mesylate 2 relatlimab 1 pembrolizumab 1 camrelizumab 1 apatinib 1 Specimen Handling 1 Radiotherapy 1 Radiation 1 Protons 1 Proton Therapy 1 Pemetrexed 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 Disulfides 1 Dasatinib 1 Cetuximab 1 CTLA-4 Antigen 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Chordoma × Proton Therapy × Clear all

NCT00496119 2025-12-16

Proton Beam Therapy for Chordoma Patients

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡